Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Registry study, no specific intervention: Registry study, no specific intervention

Study summary

The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.

Eligibility

Primary outcome measure(s)

• 3-year OS — 3 years
  3-year overall survival

Trial sites (1)

More Peking Union Medical College Hospital trials in China

Other trials for the same condition